Drug intelligence / Profile preview

JWK013

Development stage
Phase 1
Lead developer
West China Hospital of Sichuan University
Modality
Gene Therapies
Administration
Intranasal
01

Overview

JWK013 is an investigational gene therapy developed by West China Hospital, Sichuan University, for the treatment of treatment-resistant depressive disorder (TRD). It utilizes an adeno-associated virus serotype 9 (AAV9) vector to deliver the *NRF2* (Nuclear factor erythroid 2-related factor 2) gene via intranasal administration. NRF2 is a transcription factor that serves as a master regulator of the antioxidant response, inducing the expression of numerous genes that protect against oxidative stress and neuroinflammation. By overexpressing NRF2 in the brain, JWK013 aims to mitigate the inflammatory and oxidative damage implicated in the pathophysiology of depression. The therapy is currently being evaluated in a Phase 1 dose-escalation clinical trial in China to assess its safety, tolerability, and preliminary antidepressant effects in adults with TRD.

Other names
AAV9-NRF2 gene therapyAAV-9-NRF2 gene therapyAAV 9-NRF2 gene therapyNasal AAV9-NRF2
02

Targets

NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)

Beyond the preview

Go deeper on JWK013.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on JWK013.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call